跳至主要内容
临床试验/JPRN-UMIN000021101
JPRN-UMIN000021101已完成未知

Effect of supplement containing lutein on knee joint symptoms. -a randomized, double blind, placebo-controlled study- - Effect of supplement containing lutein on knee joint symptoms.

HUMA R&D CORP0 个研究点目标入组 88 人开始时间: 2016年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 74years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects receiving treatment for pain of knee 2) Subjects receiving drug treatment 3) Subject receiving treatment for hyperuricemia 4) Subject receiving treatment or having a medical history for serious disease such as diabetes, cardiovascular disease, liver disease, kidney disease and heart disease 5) Subjects having rheumatism 6) Subjects having surgery of the knee or those who need knee surgery 7) Subjects having drug treatment plan for joint, during the test period 8) Subjects who has carried out the intra-articular injection of hyaluronic acid within two weeks, or the intra-articular injection of steroids within three months prior to the start of the present study 9) Subject having a medical history for disease related to bone and joints, such as fracture or sprain within three months 10) Subject taking lutein, salmon cartilage extract, proteoglycan, type 2 collagen, N-acetyl glucosamine, and other health food (hyaluronic acid, glucosamine, chondroitin sulfate, etc.) that might affect the evaluation of the test 11) Subject taking pharmaceutical products(especially glucosamine, chondroitin sulfate, vitamin D, containing amino acid, the drug treatment of osteoporosis) 12) Subject using a cane, routinely 13) Subject taking warfarin 14) Subject presenting known allergy to food or drug 15) For female subject: pregnancy or breast feeding, or possibility of pregnancy, or intention to be pregnant during the study 16) Subject deemed unsuitable by the investigator or test sharing doctor

研究者

发起方
HUMA R&D CORP

相似试验